恩替卡韦、替诺福韦酯、L - 氟甲脲嘧啶、替比夫定等。
Entecavir, FTC, L-FMAU, LdT and others.
作者信息
Buti Maria, Esteban Rafael
机构信息
Liver Unit, Hospital General Universitari Vall d'Hebron, Paseo Valle de Hebron 119, Barcelona 08035, Spain.
出版信息
J Hepatol. 2003;39 Suppl 1:S139-42. doi: 10.1016/s0168-8278(03)00316-7.
Abstract
To summarize, the future of chronic hepatitis B therapy seems to be the combination of different drugs. Ideally, the optimal drugs to combine would meet the following criteria: they should be orally applicable, they should have an excellent safety profile and the duration of therapy should limited. Currently, the drugs most likely to fulfill these criteria are the nucleoside analogs.
摘要
总之，慢性乙型肝炎治疗的未来似乎在于不同药物的联合使用。理想情况下，联合使用的最佳药物应满足以下标准：它们应可口服，应具有出色的安全性，且治疗疗程应有限。目前，最有可能满足这些标准的药物是核苷类似物。
Zotero 插件